Biohaven Ltd. Common Shares
$BHVNHot on XNYSEGLP-1
15Posts · 7D
13Authors
+1400%Vs prior 7D
→See which stocks are pulling investors into the conversation, what the crowd is saying, and whether the attention is broad or concentrated.
Top stocks by X chatter · rolling 7-day window
Hims & Hers Health reportedly raised full-year revenue guidance to $3.1-3.3B and posted 38% Q2 growth, yet the stock dropped roughly 9-14% post-earnings due to an $86.3M net loss and ongoing FTC scrutiny.
Research →Open any ticker to investigate the catalyst, price action, filings, earnings, news, positioning, and risks.